SATELLITE Study (feaSibility sAfeTy Efficacy dostarLimab earLy-stage defIcient endomeTrial cancEr)

Clinical trial NCT06278857 · RECRUITING

Trial details

NCT number: NCT06278857
Sponsor: Queensland Centre for Gynaecological Cancer
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Endometrial Cancer Stage I Mmr Deficiency Endometrioid Endometrial Adenocarcinoma Immune-related Adverse Event

Start date: 2024-08-01
Primary completion: 2026-06-30
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.